In section Market Quotes

Mochida Pharmaceutical’s First-Half Net Profit Rises to ¥6.71 Billion

Mochida Pharmaceutical reported net profit of ¥6.71 billion for the six months ended September 30, up from ¥3.86 billion a year earlier. The Japanese drugmaker also recorded higher revenue, operating profit and pretax profit for the half-year.

By Money Talk·November 9, 2026·2 min read·263 reads

Revenue increased to ¥64.37 billion from ¥54.99 billion in the same period of 2025. Operating profit rose to ¥7.10 billion, compared with ¥4.97 billion, while pretax profit reached ¥8.13 billion, up from ¥5.18 billion.

Earnings per share were ¥190.01, versus ¥108.79 a year earlier. The results are based on Japanese accounting standards.

Mochida Pharmaceutical’s First-Half Net Profit Rises to ¥6.71 Billion

Comments (0)